Item Type | Name |
Concept
|
Heart Valve Prosthesis
|
Concept
|
Heart-Assist Devices
|
Concept
|
Heart Valve Prolapse
|
Concept
|
Heart Failure
|
Concept
|
National Heart, Lung, and Blood Institute (U.S.)
|
Concept
|
Heart Arrest
|
Concept
|
Heart Valve Prosthesis Implantation
|
Concept
|
Heart Transplantation
|
Concept
|
American Heart Association
|
Concept
|
Heart Ventricles
|
Concept
|
Heart Valve Diseases
|
Concept
|
Heart Diseases
|
Academic Article
|
Differential expression of the IFN-gamma-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell alpha chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection.
|
Academic Article
|
Allograft arteriosclerosis and immune-driven angiogenesis.
|
Academic Article
|
Combined percutaneous coronary intervention and valve surgery.
|
Academic Article
|
Placement of the TandemHeart percutaneous left ventricular assist device.
|
Academic Article
|
Treatment of unprotected left main coronary artery stenosis in a 5-year-old heart transplant patient using a sirolimus-eluting stent.
|
Academic Article
|
Argatroban in short-term percutaneous ventricular assist subsequent to heparin-induced thrombocytopenia.
|
Academic Article
|
Percutaneous closure of aortic prosthetic paravalvular regurgitation with two amplatzer septal occluders.
|
Academic Article
|
Hybrid cardiovascular procedures.
|
Academic Article
|
Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction.
|
Academic Article
|
Combined PCI and minimally invasive heart valve surgery for high-risk patients.
|
Academic Article
|
Development of a network to test strategies in cardiovascular cell delivery: the NHLBI-sponsored Cardiovascular Cell Therapy Research Network (CCTRN).
|
Academic Article
|
Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): Rationale and design.
|
Academic Article
|
LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction.
|
Academic Article
|
Novel multi-functional life support system.
|
Academic Article
|
Aortic root spontaneous echocardiographic contrast due to haemodynamic support with a percutaneous left ventricular assist device (TandemHeart).
|
Academic Article
|
Efficacy and safety of percutaneous life support during high-risk percutaneous coronary intervention, refractory cardiogenic shock and in-laboratory cardiopulmonary arrest.
|
Academic Article
|
Hybrid options for treating cardiac disease.
|
Academic Article
|
Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial.
|
Academic Article
|
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
Academic Article
|
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
Academic Article
|
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
Academic Article
|
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
Academic Article
|
Stem cell therapy for chronic heart failure: an updated appraisal.
|
Academic Article
|
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the American College of Emergency Physicians and Society for Cardiovascular Angiography and Interventions.
|
Academic Article
|
Considerations in antithrombotic therapy among patients undergoing transcatheter aortic valve implantation.
|
Academic Article
|
Peripheral vascular complications during transcatheter aortic valve replacement: management and potential role of chronic steroid use.
|
Academic Article
|
High prevalence of occult pulmonary venous hypertension revealed by fluid challenge in pulmonary hypertension.
|
Academic Article
|
Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes.
|
Academic Article
|
Percutaneous management of RetroFlex 3 balloon rupture and separation of the Edwards Sapien delivery system.
|
Academic Article
|
Prognostic value of acute vasodilator response in pulmonary arterial hypertension: beyond the "classic" responders.
|
Academic Article
|
2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.
|
Academic Article
|
2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial Infarction: An update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.
|
Academic Article
|
Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial.
|
Academic Article
|
Identification of Bone Marrow Cell Subpopulations Associated With Improved Functional Outcomes in Patients With Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN Trial.
|
Academic Article
|
Clinical Outcomes in Different Types of Aortic Stenosis as Assessed by Doppler Echocardiography.
|
Academic Article
|
Bioprosthetic tricuspid valve thrombosis: Percutaneous PFO closure to improve hypoxia and respiratory failure.
|
Academic Article
|
Comparison of paravalvular aortic leak characteristics in the Medtronic CoreValve versus Edwards Sapien Valve: Paravalvular aortic leak characteristics.
|
Academic Article
|
TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year Analysis.
|
Academic Article
|
A comparison of valve-in-valve transcatheter aortic valve replacement in failed stentless versus stented surgical bioprosthetic aortic valves.
|